Huangjia ruangan granules with entecavir for fibrosis regression in chronic hepatitis B: a multicenter, randomized, double-blind, phase II trial

Authors
Category Primary study
Conference34th Annual Meeting of the Asian Pacific Association for the Study of the Liver, APASL 2025
Year 2025
This article has no abstract
Epistemonikos ID: 2326972b3dc1994aebbc6ed2032f804ee94cfcaa
First added on: Jan 10, 2026